Raiffeisen Bank International Ag Bristol Myers Squibb CO Transaction History
Raiffeisen Bank International Ag
- $6.27 Trillion
- Q1 2025
A detailed history of Raiffeisen Bank International Ag transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Raiffeisen Bank International Ag holds 383,299 shares of BMY stock, worth $18.5 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
383,299
Previous 367,240
4.37%
Holding current value
$18.5 Million
Previous $20.6 Billion
11.73%
% of portfolio
0.37%
Previous 0.31%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.24 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.66 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.22 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.58 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.21 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $103B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...